首页> 外文期刊>BMC Pregnancy and Childbirth >When to perform curettage after uterine artery embolization for cesarean scar pregnancy: a clinical study
【24h】

When to perform curettage after uterine artery embolization for cesarean scar pregnancy: a clinical study

机译:当子宫动脉栓塞治疗剖腹产瘢痕期后,临床研究

获取原文
       

摘要

Prophylactic uterine artery embolization (UAE) combined with subsequent curettage is suggested as an effective and minimally invasive treatment strategy for cesarean scar pregnancy (CSP) with a high bleeding risk. However, the timing of curettage after UAE remains to be studied. Thus, we aimed to identify the optimal time interval to perform curettage after UAE in patients with CSP. We conducted a retrospective cohort study in a large medical center for women and children in Southwest China. CSP patients treated by UAE combined with subsequent curettage were included and grouped by the treatment time interval between these two procedures. The clinical outcomes among arms were compared by univariate and multivariable analysis. Our study included 314 CSP patients who received this combination treatment in our department from January 2014 to December 2019. The median time interval between UAE and curettage was 48?h, with a range of 12-168?h among all participants. Thirty-two patients (10.2%) experienced intraoperative hemorrhage (blood loss ≥200?mL). Intrauterine balloon tamponade was used in 17 cases (5.4%). In 14 cases (4.5%), the procedure was converted to laparoscopy (or laparotomy). In the cohort study, patients with longer treatment intervals had more intraoperative blood loss and a higher incidence of complications than those with shorter intervals (P 72?h had an adjusted odds ratio of 3.37 (95% confidence interval: 1.40-8.09). We suggest that curettage not be delayed longer than 72?h after UAE in this combined treatment of CSP.
机译:预防性子宫动脉栓塞(UAE)与随后的刮宫相结合,作为剖腹产瘢痕妊娠(CSP)的有效和微创治疗策略,具有较高的出血风险。然而,阿联酋后粘合剂的定时仍然被研究。因此,我们旨在识别CSP患者在UAE之后进行uRETTAGE进行最佳时间间隔。我们在中国西南部的妇女和儿童大型医疗中心进行了回顾性队列研究。由阿联酋治疗的CSP患者结合随后的刮宫,并通过这两种方法之间的治疗时间间隔进行分组。通过单变量和多变量分析比较了武器之间的临床结果。我们的研究包括314名CSP患者,在2014年1月至2019年12月期间在我们的部门获得了这种联合治疗。阿联酋和刮宫之间的中位时间间隔为48?H,所有参与者之间的范围为12-168?H。三十二名患者(10.2%)经历了术中出血(血液损失≥200?mL)。宫内气球局局长于17例(5.4%)。在14例(4.5%)中,该程序转化为腹腔镜检查(或剖腹手术)。在队列研究中,治疗时间间隔较长的患者具有更多的术中失血和比较短的间隔的并发症的发生率更高(P 72〜H具有3.37的调节的差率比(95%置信区间:1.40-8.09)。我们提示在这种组合治疗CSP的情况下,刮宫不会延迟超过72℃。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号